Long-term disease-free survival achieved by anti-angiogenic therapy plus surgery in a hepatocellular carcinoma patient with extensive liver involvement and lung metastases
Journal
Journal of the Formosan Medical Association
Journal Volume
113
Journal Issue
8
Pages
577-578
Date Issued
2014
Author(s)
SDGs
Other Subjects
alpha fetoprotein; bevacizumab; capecitabine; fluorodeoxyglucose f 18; alpha fetoprotein; angiogenesis inhibitor; antineoplastic antimetabolite; bevacizumab; capecitabine; adult; alpha fetoprotein blood level; antiangiogenic therapy; article; cancer combination chemotherapy; cancer surgery; cancer survival; case report; computer assisted tomography; disease free survival; female; follow up; human; human tissue; liver biopsy; liver cell carcinoma; liver resection; long term survival; lung metastasis; multimodality cancer therapy; phase 2 clinical trial (topic); positron emission tomography; splenectomy; systemic therapy; treatment response; tumor biopsy; young adult; Carcinoma, Hepatocellular; disease free survival; Liver Neoplasms; Lung Neoplasms; pathology; secondary; Splenic Neoplasms; Adult; alpha-Fetoproteins; Angiogenesis Inhibitors; Antimetabolites, Antineoplastic; Bevacizumab; Capecitabine; Carcinoma, Hepatocellular; Disease-Free Survival; Female; Hepatectomy; Humans; Liver Neoplasms; Lung Neoplasms; Splenic Neoplasms; Young Adult
Publisher
Elsevier B.V.
Type
journal article